Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lennard

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
British Journal of Cancer|July 1, 1993
Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia?L Lennard, H A Davies, J S Lilleyman
Clinical Pharmacology and Therapeutics|August 1, 1989
Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphismL Lennard, J A Van Loon, R M Weinshilboum
Cancer Chemotherapy and Pharmacology|July 12, 2002
Leucocyte versus erythrocyte thioguanine nucleotide concentrations in children taking thiopurines for acute lymphoblastic leukaemiaD L Lancaster, N Patel, L Lennard, et al.
British Journal of Clinical Pharmacology|June 26, 2001
6-Thioguanine in children with acute lymphoblastic leukaemia: influence of food on parent drug pharmacokinetics and 6-thioguanine nucleotide concentrationsD L Lancaster, N Patel, L Lennard, et al.
Journal of Hepatology|September 1, 1995
Azathioprine-induced myelosuppression due to thiopurine methyltransferase deficiency in a patient with autoimmune hepatitisZ Ben Ari, A Mehta, L Lennard, et al.
Therapeutic Drug Monitoring|August 1, 1997
Pharmacokinetics of mercaptopurine: plasma drug and red cell metabolite concentrations after an oral doseJ Welch, L Lennard, G C Morton, et al.
Gut|July 13, 2004
Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel diseaseS Wright, D S Sanders, A J Lobo, et al.
Medical and Pediatric Oncology|October 1, 1997
Thiopurine methyltransferase deficiency in childhood lymphoblastic leukaemia: 6-mercaptopurine dosage strategiesL Lennard, I J Lewis, M Michelagnoli, et al.
British Journal of Clinical Pharmacology|February 1, 1987
Metabolism of azathioprine to 6-thioguanine nucleotides in patients with pemphigus vulgarisL Lennard, C I Harrington, M Wood, et al.
Archives of Disease in Childhood|November 1, 1993
Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemiaL Lennard, B E Gibson, T Nicole, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|July 1, 1993
Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia?L Lennard, H A Davies, J S Lilleyman
Clinical Pharmacology and Therapeutics|August 1, 1989
Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphismL Lennard, J A Van Loon, R M Weinshilboum
Cancer Chemotherapy and Pharmacology|July 12, 2002
Leucocyte versus erythrocyte thioguanine nucleotide concentrations in children taking thiopurines for acute lymphoblastic leukaemiaD L Lancaster, N Patel, L Lennard, et al.
British Journal of Clinical Pharmacology|June 26, 2001
6-Thioguanine in children with acute lymphoblastic leukaemia: influence of food on parent drug pharmacokinetics and 6-thioguanine nucleotide concentrationsD L Lancaster, N Patel, L Lennard, et al.
Journal of Hepatology|September 1, 1995
Azathioprine-induced myelosuppression due to thiopurine methyltransferase deficiency in a patient with autoimmune hepatitisZ Ben Ari, A Mehta, L Lennard, et al.
Therapeutic Drug Monitoring|August 1, 1997
Pharmacokinetics of mercaptopurine: plasma drug and red cell metabolite concentrations after an oral doseJ Welch, L Lennard, G C Morton, et al.
Gut|July 13, 2004
Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel diseaseS Wright, D S Sanders, A J Lobo, et al.
Medical and Pediatric Oncology|October 1, 1997
Thiopurine methyltransferase deficiency in childhood lymphoblastic leukaemia: 6-mercaptopurine dosage strategiesL Lennard, I J Lewis, M Michelagnoli, et al.
British Journal of Clinical Pharmacology|February 1, 1987
Metabolism of azathioprine to 6-thioguanine nucleotides in patients with pemphigus vulgarisL Lennard, C I Harrington, M Wood, et al.
Archives of Disease in Childhood|November 1, 1993
Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemiaL Lennard, B E Gibson, T Nicole, et al.
Pageof 9